Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association

ABSTRACT: DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association

PROVIDER: PRJNA628610 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association

Project description:This study evaluate the methylation profile of 84 clinically sporadic pancreatic neuroendocrine tumors (PanNETs) with associated clinical and genomic information. We identified three subgroups of PanNETs, termed T1, T2 and T3, with distinct patterns of methylation. The T1 subgroup was enriched for functional tumors and ATRX, DAXX and MEN1 wild-type genotypes. The T2 subgroup contained tumors with mutations in ATRX, DAXX and MEN1 and recurrent patterns of chromosomal losses in half of the genome with no association between regions with recurrent LOH and methylation levels. T2 tumors were larger and had lower methylation in the MGMT gene body, which showed positive correlation with gene expression. The T3 subgroup harboured mutations in MEN1 with recurrent LOH of chromosome 11, was enriched for grade G1 tumors and showed histological parameters associated with better prognosis. Our results suggest a role for methylation in both driving tumorigenesis and potentially stratifying prognosis in PanNETs. These set of normal adjacent pancreata was compared to ICGC pancreatic neuroendocrine tumour methylation. We identified CpG sites located in promoter regions with low levels of methylation (beta value <0.3) in all normal adjacent pancreata and from those selected the most variable probes with a standard deviation >0.20 of DNA methylation levels across all tumors to identify sub-groups.

2021-02-16 | GSE149395 | GEO

DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association.

Project description:Here we report the DNA methylation profile of 84 sporadic pancreatic neuroendocrine tumors (PanNETs) with associated clinical and genomic information. We identified three subgroups of PanNETs, termed T1, T2 and T3, with distinct patterns of methylation. The T1 subgroup was enriched for functional tumors and ATRX, DAXX and MEN1 wild-type genotypes. The T2 subgroup contained tumors with mutations in ATRX, DAXX and MEN1 and recurrent patterns of chromosomal losses in half of the genome with no association between regions with recurrent loss and methylation levels. T2 tumors were larger and had lower methylation in the MGMT gene body, which showed positive correlation with gene expression. The T3 subgroup harboured mutations in MEN1 with recurrent loss of chromosome 11, was enriched for grade G1 tumors and showed histological parameters associated with better prognosis. Our results suggest a role for methylation in both driving tumorigenesis and potentially stratifying prognosis in PanNETs.

| S-EPMC7859232 | biostudies-literature

DNA methylation patterns of neuroendocrine neoplasms

Project description:DNA methylation patterns of neuroendocrine neoplasms

| PRJNA1270930 | ENA

DNA methylation patterns of neuroendocrine neoplasms

Project description:Neuroendocrine neoplasms (NEN) are thought to originate from diffuse endocrine networks and therefore most frequently occur in the gastrointestinal tract and lungs. The liver is a frequent site of metastasis of NEN but also the presence of primary hepatic NEN (PHNEN) has been proposed. Due to the impact on disease management, it is urgently required to discriminate the origin of hepatic NEN metastases and to identify clinically relevant subgroups.

2025-09-29 | GSE298677 | GEO

DNA methylation patterns facilitate tracing the origin of neuroendocrine neoplasms

Project description:Neuroendocrine neoplasms (NEN) are thought to originate from diffuse endocrine networks and therefore most frequently occur in the gastrointestinal tract and lungs. The liver is a frequent site of metastasis of NEN but also the presence of primary hepatic NEN has been proposed. Due to the impact on disease management, it is urgently required to discriminate the origin of hepatic NEN metastases and to identify clinically relevant subgroups.

2025-09-29 | GSE253176 | GEO

Expression profiling of small intestine neuroendocrine tumors identifies subclasses with clinical relevance, therapeutic target and biomarkers for prognosis

Project description:We sought to define the gene expression profiles of small intestine neuroendocrine tumors (SI-NETs) in order to identify clinically relevant subgroups of tumors, prognostic markers and novel targets for treatment.

2016-12-31 | GSE65286 | GEO

Fungi-substrate association patterns in boreal forests

Project description:Fungi-substrate association patterns in boreal forests

| PRJEB106125 | ENA

miR-203 and miR-205 expression patterns identify subgroups of prognosis in cutaneous squamous cell carcinoma

Project description:miR-203 and miR-205 expression patterns identify subgroups of prognosis in cutaneous squamous cell carcinoma

| PRJNA292460 | ENA

DNA methylation patterns facilitate tracing the origin of neuroendocrine neoplasms

Project description:DNA methylation patterns facilitate tracing the origin of neuroendocrine neoplasms

| PRJNA1064160 | ENA

Medulloblastoma in adults: Cytogenetic phenotypes identify prognostic subgroups

Project description:Medulloblastoma in adults: Cytogenetic phenotypes identify prognostic subgroups